HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $517,000 | +23.7% | 19,570 | -8.5% | 0.01% | +20.0% |
| Q4 2018 | $418,000 | -0.7% | 21,385 | -0.5% | 0.01% | 0.0% |
| Q3 2018 | $421,000 | -6.0% | 21,484 | -20.5% | 0.01% | 0.0% |
| Q2 2018 | $448,000 | +0.2% | 27,028 | -14.2% | 0.01% | 0.0% |
| Q1 2018 | $447,000 | -24.5% | 31,513 | -22.3% | 0.01% | -16.7% |
| Q4 2017 | $592,000 | -33.8% | 40,544 | -42.5% | 0.01% | -40.0% |
| Q3 2017 | $894,000 | +4.6% | 70,506 | -2.2% | 0.01% | 0.0% |
| Q2 2017 | $855,000 | +33.8% | 72,060 | +66.8% | 0.01% | +25.0% |
| Q1 2017 | $639,000 | -29.4% | 43,198 | -22.8% | 0.01% | -27.3% |
| Q4 2016 | $905,000 | -48.0% | 55,977 | -41.6% | 0.01% | -50.0% |
| Q3 2016 | $1,739,000 | +23.2% | 95,928 | +136.1% | 0.02% | +15.8% |
| Q2 2015 | $1,411,000 | -30.0% | 40,623 | -47.7% | 0.02% | -26.9% |
| Q1 2015 | $2,017,000 | – | 77,655 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |